Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123818742 | 12381874 | 2 | F | 20160805 | 20160518 | 20160811 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-037847 | BRISTOL MYERS SQUIBB | 45.00 | YR | F | Y | 0.00000 | 20160811 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123818742 | 12381874 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, UNK | Y | 21436 | 10 | MG | QD | ||||||
| 123818742 | 12381874 | 2 | C | LAMICTAL | LAMOTRIGINE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123818742 | 12381874 | 1 | Bipolar II disorder |
| 123818742 | 12381874 | 2 | Bipolar disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123818742 | 12381874 | OT |
| 123818742 | 12381874 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123818742 | 12381874 | Depression | |
| 123818742 | 12381874 | Off label use | |
| 123818742 | 12381874 | Suicidal ideation | |
| 123818742 | 12381874 | Tetany |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123818742 | 12381874 | 1 | 20160505 | 201605 | 0 |